Quick Comparison
| Hydroquinone | Tretinoin | |
|---|---|---|
| Typical Concentration | OTC (where available): 2%. Prescription: 4%. Apply to dark spots only (not entire face) once or twice daily. Use in 3-4 month cycles with 2-3 month breaks. Always use with sunscreen (SPF 30+) — without it, hydroquinone is ineffective. | Concentrations: 0.025%, 0.05%, 0.1%. Start with 0.025% every other night for 4-6 weeks, then increase frequency. Apply pea-sized amount to dry face 20 minutes after cleansing. Always use with SPF 30+ during the day. Retinization period: 4-12 weeks of initial irritation. |
| Application | Topical (cream, gel, serum). Apply precisely to hyperpigmented areas. Avoid contact with normal skin. | Topical (cream, gel, microsphere). Apply to clean, dry skin at night. Microsphere formulations (Retin-A Micro) release tretinoin slowly, reducing irritation. |
| Research Papers | 9 papers | 10 papers |
| Categories |
Mechanism of Action
Hydroquinone
Hydroquinone inhibits tyrosinase through multiple mechanisms: competitive alternative substrate, oxidation to semiquinone radicals generating ROS that damage melanocyte mitochondria and ER, copper chelation at tyrosinase active site. Inhibits RNA/DNA synthesis via ribonucleotide reductase interference. Causes melanosome degradation through membrane disruption. Dramatic melanin reduction — eumelanin and pheomelanin pathways suppressed. Selectively affects hyperactive melanocytes, sparing quiescent ones. Fades pigmentation without permanently altering baseline skin color. Pigmentation returns when treatment stops (melanocyte stem cells intact). Enhanced with retinoids (penetration) and sunscreen (prevents UV rebound).
Tretinoin
Tretinoin binds nuclear retinoic acid receptors (RAR-alpha, beta, gamma), forming RAR/RXR heterodimers that bind retinoic acid response elements and activate gene transcription. This accelerates keratinocyte proliferation, reducing stratum corneum transit from ~28 to ~14 days. In the dermis, tretinoin stimulates fibroblasts and upregulates collagen I and III via TGF-beta while downregulating MMP-1, MMP-3, and MMP-9 that degrade the extracellular matrix. It normalizes melanocyte distribution and melanosome transfer. In acne, it prevents microcomedo formation by normalizing follicular keratinocyte differentiation and reducing corneocyte cohesion. RAR activation also modulates genes for epidermal growth factors and differentiation markers.
Risks & Safety
Hydroquinone
Common
Mild redness, stinging, dryness.
Serious
Exogenous ochronosis (paradoxical blue-grey darkening) with prolonged use >6 months, particularly in darker skin tones. Irritant and allergic contact dermatitis.
Rare
Nail discoloration, peripheral neuropathy (extremely rare, systemic exposure).
Tretinoin
Common
Dryness, peeling, redness, increased sun sensitivity (mandatory SPF). Initial purging (breakouts) for 4-8 weeks.
Serious
Teratogenic — absolutely contraindicated in pregnancy and breastfeeding.
Rare
Severe irritant contact dermatitis, eczema flare-ups.
Full Profiles
Hydroquinone →
The most potent topical depigmenting agent available and the gold standard prescription treatment for melasma and stubborn hyperpigmentation. Hydroquinone inhibits tyrosinase more strongly than any OTC alternative. However, it carries risks with long-term use (ochronosis — paradoxical darkening) and is restricted or banned in many countries. Best used in cycles of 3-4 months under dermatologist guidance.
Tretinoin →
The gold standard anti-aging ingredient with the most clinical evidence of any topical. Tretinoin (all-trans retinoic acid) is the active form of vitamin A that directly binds to retinoic acid receptors in skin cells. It accelerates cell turnover, stimulates collagen synthesis, reduces fine lines and wrinkles, fades hyperpigmentation, and improves skin texture. Prescription-only in most countries.